Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery
PORTLAND, Ore., April 24, 2025 /PRNewswire/ — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in…